Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)
Clinical trial NCT00215670 · COMPLETED
Trial details
- NCT number
- NCT00215670
- Sponsor
- Eyetech Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.